Arturo Molina
Equibles does not estimate personal net worth.
Get an email with a short summary when Protagonist Therapeutics, Inc publishes a filing, an earnings call transcript or a press release.
Get PTGX alertsAbout Arturo Molina
Sutro Biopharma, Inc. reported in an 8-K filed October 24, 2022 that Arturo Molina resigned as Chief Medical Officer, effective November 4, 2022. The proxy statement of Protagonist Therapeutics, Inc reports total compensation of $4,095,230 for Arturo Molina in fiscal 2025, including a base salary of $572,000. Disclosed compensation is on record for 4 fiscal years. Protagonist Therapeutics, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protagonist Therapeutics, Inc includes Dinesh Patel (CEO and Board Member), Dinesh V. Patel (CEO and Board Member), Asif Ali (CFO) and 6 others.
“On October 18, 2022, Dr. Arturo Molina notified Sutro Biopharma, Inc. (the "Company") that he will resign from his role as Chief Medical Officer of the Company, effective November 4, 2022.”
Affiliation history
-
Protagonist Therapeutics, Inc (PTGX)
Proxy statement
CurrentStart not stated–present
Last confirmed April 28, 2026
-
Sutro Biopharma, Inc. (STRO)
Proxy statement
Start not stated–2022-11-04
Company network
Leadership on record at Protagonist Therapeutics, Inc
- Dinesh Patel CEO, Board Member
- Dinesh V. Patel CEO, Board Member
- Asif Ali CFO
- Daniel N. Swisher, Jr. Board Member
- Dinesh V. Patel, Ph.D. Board Member
- Lewis T. "Rusty" Williams, M.D., Ph.D. Board Member
- Lewis T. “Rusty” Williams Board Member
- Sarah A. O'Dowd Board Member
- Sarah O'Dowd Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Protagonist Therapeutics, Inc (PTGX) | M.D., M.S., F.A.C.P. Chief Medical Officer | $572,000 | $4,095,230 |
| 2024 | Protagonist Therapeutics, Inc (PTGX) | M.D., M.S., F.A.C.P. Chief Medical Officer | $550,000 | $3,464,201 |
| 2019 | Sutro Biopharma, Inc. (STRO) | M.D., M.S., FACP Chief Medical Officer | $453,500 | $947,360 |
| 2018 | Sutro Biopharma, Inc. (STRO) | M.D., M.S., FACP Chief Medical Officer | $440,300 | $3,354,080 |